Get my own profile
Public access
View all1 article
0 articles
available
not available
Based on funding mandates
Co-authors
- Joel CherryAmyris, Inc.Verified email at amyris.com
- Professor Gideon Davies, FRS, FMedSciYSBL, Department of Chemistry, University of YorkVerified email at york.ac.uk
- Jens Erik NielsenVice President, Enzyme Research, Novozymes A/SVerified email at novozymes.com
- Steffen DanielsenSenior manager, NovozymesVerified email at novozymes.com
- Andrzej Marek BrzozowskiUniversity of YorkVerified email at york.ac.uk
- Leila Lo LeggioUniversity of CopenhagenVerified email at chem.ku.dk
- Johan TurkenburgUniversity of YorkVerified email at york.ac.uk
- Sine LarsenUniversity of CopenhagenVerified email at chem.ku.dk
- Martin NobleProfessor of Structural Biology and Anticancer Drug DesignVerified email at ncl.ac.uk
- Jose M. Sanchez-RuizUniversidad de Granada (Spain)Verified email at ugr.es
- david rodriguez larreaUniversidad del Pais VascoVerified email at ehu.es
- Vincent EijsinkProfessor ved Norges Miljø- og Biovitenskapelige Universitet (NMBU)Verified email at nmbu.no
- Associate Professor Jerome Le NoursDepartment of Molecular Biology & Biochemistry - Biomedicine Discovery Institute - Monash UniversityVerified email at monash.edu
- Emily MundorffAsst Professor of Chemistry, Hofstra UniversityVerified email at hofstra.edu
- Sridhar GovindarajanATUMVerified email at atum.bio
- Torbjörn GräslundProfessor at KTH Royal Institute of Technology, Stockholm, SwedenVerified email at kth.se
- Fred OpperdoesEmeritus professor, Université catholique de LouvainVerified email at uclouvain.be
- Katherine E. McAuleyPaul Scherrer InstitutVerified email at psi.ch